Froniter Biotechnologies: Net loss of 97.3526 million yuan in the first half of 2025, a year-on-year narrowing

Zhitong
2025.08.29 09:34

Froniter Biotechnologies announced that in the first half of 2025, operating revenue was 58.6398 million yuan, a year-on-year increase of 14.85%. The net loss attributable to shareholders of the listed company was 97.3526 million yuan, compared to a net loss of 160 million yuan in the same period last year. Basic earnings per share were -0.26 yuan/share, compared to -0.43 yuan/share in the same period last year

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.